Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 09-2010 | 09-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,219 | -1,901 | -5,182 | N/A | -6,770 |
| Depreciation Amortization | 34 | 45 | 45 | 40 | 38 |
| Accounts receivable | N/A | N/A | N/A | N/A | 1 |
| Other Working Capital | 510 | 8 | -24 | 70 | 1,544 |
| Other Operating Activity | -918 | 801 | 3,605 | 3,500 | 2,852 |
| Operating Cash Flow | $-1,593 | $-1,047 | $-1,556 | $3,610 | $-2,336 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -39 | -11 | -59 | N/A | -216 |
| Other Investing Activity | -39 | -11 | -59 | -50 | -216 |
| Investing Cash Flow | $-39 | $-11 | $-59 | $-50 | $-216 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 75 | N/A | 1,300 |
| Debt Issued | 56 | 571 | -373 | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -592 |
| Common Stock Issued | N/A | N/A | 25 | N/A | N/A |
| Other Financing Activity | 1,645 | 491 | 914 | 560 | 2,010 |
| Financing Cash Flow | $1,701 | $1,061 | $641 | $560 | $2,718 |
| Beginning Cash Position | 3 | N/A | 974 | N/A | 808 |
| End Cash Position | 72 | 3 | N/A | N/A | 974 |
| Net Cash Flow | $69 | $3 | $-974 | $4,120 | $166 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,593 | -1,047 | -1,556 | 3,610 | -2,336 |
| Free Cash Flow | -1,593 | -1,047 | -1,556 | 3,610 | -2,336 |